Targeted delivery of quantum dots to the HER2-expressing tumor using recombinant antibodies

I. V. Balalaeva, T. A. Zdobnova, E. A. Sokolova, S. M. Deyev

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Targeted delivery of semiconductor quantum dots (QDs) to tumors overexpressing HER2 cancer marker has been demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of 4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.

Original languageEnglish
Pages (from-to)536-542
Number of pages7
JournalRussian Journal of Bioorganic Chemistry
Volume41
Issue number5
DOIs
Publication statusPublished - 29 Sep 2015
Externally publishedYes

Fingerprint

Quantum Dots
Semiconductor quantum dots
Tumors
Antibodies
Neoplasms
Nanoparticles
Bearings (structural)
Immunoglobulin Fragments
Semiconductors
Proteins
Recombinant Proteins
Heterografts
Fusion reactions
Cells
Breast Neoplasms
Bacillus amyloliquefaciens barstar protein
Bacillus amyloliquefaciens ribonuclease

Keywords

  • cancer marker HER2
  • D5scFv
  • fluorescence
  • quantum dots

ASJC Scopus subject areas

  • Organic Chemistry
  • Biochemistry

Cite this

Targeted delivery of quantum dots to the HER2-expressing tumor using recombinant antibodies. / Balalaeva, I. V.; Zdobnova, T. A.; Sokolova, E. A.; Deyev, S. M.

In: Russian Journal of Bioorganic Chemistry, Vol. 41, No. 5, 29.09.2015, p. 536-542.

Research output: Contribution to journalArticle

Balalaeva, I. V. ; Zdobnova, T. A. ; Sokolova, E. A. ; Deyev, S. M. / Targeted delivery of quantum dots to the HER2-expressing tumor using recombinant antibodies. In: Russian Journal of Bioorganic Chemistry. 2015 ; Vol. 41, No. 5. pp. 536-542.
@article{0f53e4ef7cd3444998ef057a5a44d5b3,
title = "Targeted delivery of quantum dots to the HER2-expressing tumor using recombinant antibodies",
abstract = "Targeted delivery of semiconductor quantum dots (QDs) to tumors overexpressing HER2 cancer marker has been demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of 4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.",
keywords = "cancer marker HER2, D5scFv, fluorescence, quantum dots",
author = "Balalaeva, {I. V.} and Zdobnova, {T. A.} and Sokolova, {E. A.} and Deyev, {S. M.}",
year = "2015",
month = "9",
day = "29",
doi = "10.1134/S1068162015050040",
language = "English",
volume = "41",
pages = "536--542",
journal = "Russian Journal of Bioorganic Chemistry",
issn = "1068-1620",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "5",

}

TY - JOUR

T1 - Targeted delivery of quantum dots to the HER2-expressing tumor using recombinant antibodies

AU - Balalaeva, I. V.

AU - Zdobnova, T. A.

AU - Sokolova, E. A.

AU - Deyev, S. M.

PY - 2015/9/29

Y1 - 2015/9/29

N2 - Targeted delivery of semiconductor quantum dots (QDs) to tumors overexpressing HER2 cancer marker has been demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of 4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.

AB - Targeted delivery of semiconductor quantum dots (QDs) to tumors overexpressing HER2 cancer marker has been demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of 4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.

KW - cancer marker HER2

KW - D5scFv

KW - fluorescence

KW - quantum dots

UR - http://www.scopus.com/inward/record.url?scp=84942590374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942590374&partnerID=8YFLogxK

U2 - 10.1134/S1068162015050040

DO - 10.1134/S1068162015050040

M3 - Article

AN - SCOPUS:84942590374

VL - 41

SP - 536

EP - 542

JO - Russian Journal of Bioorganic Chemistry

JF - Russian Journal of Bioorganic Chemistry

SN - 1068-1620

IS - 5

ER -